NextPlat Wins Multi-State Prescription Fulfillment Contract from DevotedDOc

Reuters11-05
<a href="https://laohu8.com/S/NXPL">NextPlat</a> Wins Multi-State Prescription Fulfillment Contract from DevotedDOc

NextPlat Corporation announced that its healthcare subsidiary, PharmcoRx, has been awarded a new multi-state prescription fulfillment services contract by the virtual healthcare provider DevotedDOc. Under the terms of the agreement, PharmcoRx will begin providing prescription fulfillment services to DevotedDOc patients in Florida and Georgia starting in November. The contract supports DevotedDOc's services, which include urgent care, Medication-Assisted Treatment for opioid use disorder, compounded alternatives to GLP-1s for weight loss, and Hormone Replacement Therapy. NextPlat indicated plans to expand fulfillment services with DevotedDOc beyond Florida and Georgia, as PharmcoRx is licensed as a non-resident pharmacy in several other states.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: FL15975) on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment